However, IL−6 is a significant pro-inflammatory marker for the GLP-1 release in inflammatory conditions independent of the inflammogen source, such as infections and non-infectious inflammatory conditions, including T2DM, CKD and surgery-induced trauma (figure 2) [53]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.